Loading...

Bonesupport Holding AB (publ)

2B4.FXETRA
Healthcare
Medical - Instruments & Supplies
19.60
-1.98(-9.18%)
German Market opens in 12h 50m

Bonesupport Holding AB (publ) Fundamental Analysis

Bonesupport Holding AB (publ) (2B4.F) shows moderate financial fundamentals with a PE ratio of 79.73, profit margin of 15.24%, and ROE of 21.54%. The company generates $1.2B in annual revenue with strong year-over-year growth of 30.70%.

Key Strengths

ROE21.54%
Operating Margin22.84%
Cash Position33.32%
PEG Ratio0.14
Current Ratio5.13

Areas of Concern

No major concerns flagged.
We analyze 2B4.F's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 86.9/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
86.9/100

We analyze 2B4.F's fundamental strength across five key dimensions:

Efficiency Score

Excellent

2B4.F demonstrates superior asset utilization.

ROA > 10%
16.51%

Valuation Score

Moderate

2B4.F shows balanced valuation metrics.

PE < 25
79.73
PEG Ratio < 2
0.14

Growth Score

Moderate

2B4.F shows steady but slowing expansion.

Revenue Growth > 5%
30.70%
EPS Growth > 10%
5.88%

Financial Health Score

Excellent

2B4.F maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
5.13

Profitability Score

Excellent

2B4.F achieves industry-leading margins.

ROE > 15%
21.54%
Net Margin ≥ 15%
15.24%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 2B4.F Expensive or Cheap?

P/E Ratio

2B4.F trades at 79.73 times earnings. This suggests a premium valuation.

79.73

PEG Ratio

When adjusting for growth, 2B4.F's PEG of 0.14 indicates potential undervaluation.

0.14

Price to Book

The market values Bonesupport Holding AB (publ) at 15.68 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

15.68

EV/EBITDA

Enterprise value stands at 54.83 times EBITDA. This signals the market has high growth expectations.

54.83

How Well Does 2B4.F Make Money?

Net Profit Margin

For every $100 in sales, Bonesupport Holding AB (publ) keeps $15.24 as profit after all expenses.

15.24%

Operating Margin

Core operations generate 22.84 in profit for every $100 in revenue, before interest and taxes.

22.84%

ROE

Management delivers $21.54 in profit for every $100 of shareholder equity.

21.54%

ROA

Bonesupport Holding AB (publ) generates $16.51 in profit for every $100 in assets, demonstrating efficient asset deployment.

16.51%

Following the Money - Real Cash Generation

Operating Cash Flow

Bonesupport Holding AB (publ) produces operating cash flow of $248.87M, showing steady but balanced cash generation.

$248.87M

Free Cash Flow

Bonesupport Holding AB (publ) generates strong free cash flow of $245.09M, providing ample flexibility for dividends, buybacks, or growth.

$245.09M

FCF Per Share

Each share generates $3.72 in free cash annually.

$3.72

FCF Yield

2B4.F converts 1.66% of its market value into free cash.

1.66%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

79.73

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.14

vs 25 benchmark

P/B Ratio

Price to book value ratio

15.68

vs 25 benchmark

P/S Ratio

Price to sales ratio

12.15

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.13

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.22

vs 25 benchmark

ROA

Return on assets percentage

0.17

vs 25 benchmark

ROCE

Return on capital employed

0.29

vs 25 benchmark

How 2B4.F Stacks Against Its Sector Peers

Metric2B4.F ValueSector AveragePerformance
P/E Ratio79.7328.66 Worse (Expensive)
ROE21.54%671.00% Weak
Net Margin15.24%-44168.00% (disorted) Strong
Debt/Equity0.010.33 Strong (Low Leverage)
Current Ratio5.134.49 Strong Liquidity
ROA16.51%-17052.00% (disorted) Strong

2B4.F outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bonesupport Holding AB (publ)'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

482.64%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

225.75%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

297.98%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ